You are standing in the pet shop, holding two gut supplements side by side. One costs twice as much as the other. Both list Lactobacillus acidophilus. Both quote billions of CFU. Both promise a healthier gut. You do the sensible thing and read the ingredients label. Then you put them back, none the wiser.
This is not a failure of attention. It is a failure of labelling.
The ingredients list on a dog gut supplement is, in most cases, the least useful thing printed on the packaging. It tells you what a manufacturer chose to include at the time of manufacture, described in the broadest possible taxonomic terms, with a CFU count that may bear little relation to what is actually alive in the product when your dog eats it. It says nothing about whether those ingredients have been tested in dogs, whether the formulation survives the journey from factory shelf to your dog’s colon, or whether the combination of ingredients was chosen for your dog’s biology or simply assembled from a catalogue of popular human supplement inputs.
This article is about understanding why that gap exists, what it actually means for your dog, and what a genuinely informative label would tell you instead.
Key Takeaways
- Genus and species is not enough. A label listing “Lactobacillus acidophilus” without a strain designation tells you almost nothing clinically useful. Probiotic effects are strain-specific, and most commercial labels do not provide strain-level identification.¹
- The CFU number reflects manufacture, not consumption. Probiotic bacteria die during storage. The count on the label is typically measured at the point of production, not at the point of expiry. Products stored incorrectly, or simply left on a warm shelf, may contain a fraction of the stated count by the time they reach your dog.²
- Pet supplement labelling in the UK is almost entirely unregulated. There is no mandatory pre-market approval, no independent verification of CFU counts, and no requirement to demonstrate efficacy before a product is sold. Labelling inaccuracies, including misspelled bacterial names and non-existent organisms, have been documented repeatedly in veterinary studies.³
- Your dog’s gut is not a human gut. The canine microbiome is a distinct ecosystem with its own species composition, fermentation patterns, and probiotic response profiles. Evidence from human probiotic research cannot be reliably extrapolated to dogs.⁴
- Whole-gut thinking matters more than any single ingredient. What the label cannot capture is the individual complexity of your dog’s gut, shaped by diet history, age, breed, antibiotic exposure, and metabolic profile. Effective gut support addresses that complexity rather than adding a single strain and hoping for the best.⁵
In This Guide:
- The Label Tells You the Genus – That Is Not Enough
- The CFU Number Is Almost Certainly Wrong
- The Regulation Gap Nobody Talks About
- What the Label Cannot Tell You About Your Dog’s Gut
- What to Actually Look For on a Label
- References
- Editorial Information
The Label Tells You the Genus – That Is Not Enough
When a gut supplement lists Lactobacillus acidophilus on its label, it is giving you a genus and a species. What it is almost certainly not giving you is a strain designation. That distinction matters more than most pet owners realise, and more than most brands acknowledge.
Probiotic effects are strain-specific. The research that demonstrates a particular benefit, reduced diarrhoea duration, modulation of immune response, competitive exclusion of pathogens, is conducted on a specific, named strain. That strain has a designation: Lactobacillus acidophilus NCFM, for instance, or Lactobacillus rhamnosus GG. The evidence does not automatically transfer to a different strain carrying the same species name, even if the two organisms look identical on a label. A review of the evidence base for probiotic use in dogs by Schmitz and Suchodolski noted that scientific evidence for beneficial effects across different canine conditions remains limited, and that specific strain effects, combinations, and potential side effects have not been adequately evaluated.² Knowing the genus and species gives you a starting point; it does not give you an evidence base.
This matters even more when you consider the cross-species problem. The majority of probiotic research is conducted in humans or rodent models of human disease.² The canine gastrointestinal microbiome is a distinct and complex ecosystem in its own right.¹ While metagenomic analysis has shown that the dog microbiome is more similar to the human microbiome than to that of mice or pigs, dog microbiome samples remain more closely related to other dog samples than to human samples, indicating meaningful species-level divergence.⁸ A strain selected for its performance in human clinical trials has not necessarily been evaluated in a canine gut environment, under canine digestive conditions, against a canine microbial community. The physiological differences, including transit time, intestinal pH gradients, and the relative abundance of key bacterial phyla such as Fusobacteria (which feature prominently in the healthy canine microbiome but are uncommon in humans), mean that human data cannot be assumed to translate.¹
There is also the question of what the listed organisms actually represent in the context of your dog’s own microbial community. The is a dynamic ecosystem shaped by diet, age, breed, environment, and health history.⁵ Introducing a single exogenous organism, identified only to species level, into that environment is a very different proposition from the targeted, strain-specific interventions described in the better-quality veterinary clinical literature. The label tells you a genus. What it cannot tell you is whether that genus, in that unspecified strain, in that product formulation, has any meaningful interaction with the specific microbial landscape of your dog’s gut.
The CFU Number Is Almost Certainly Wrong
Colony-forming units – CFU – is the standard measure of probiotic quantity. A product listing 5 billion CFU per serving sounds substantial. The question is: 5 billion at what point in time, and under what conditions?
CFU counts in commercial probiotic supplements are typically determined at the time of manufacture.³ Probiotic bacteria are living organisms, and living organisms die. The rate at which they die depends on temperature, humidity, packaging integrity, exposure to oxygen, and the particular stability characteristics of each strain. A product that genuinely contained 5 billion viable organisms when it left the manufacturing facility may contain significantly fewer by the time it arrives in your home, and fewer still by the time your dog finishes the bag or tub. Guidance from Cornell University’s Riney Canine Health Center suggests a daily intake of 1 to 10 billion CFU for dogs, but notes that not all products deliver viable organisms in those quantities at the point of consumption.⁶
The concern is not theoretical. An assessment of 25 commercial veterinary probiotic products by Weese and Martin found that only two products had accurate labels and contained viable bacteria that matched their claims. The majority contained fewer organisms than stated. Three products listed organisms that did not exist.³ This is a study from 2011, but there is no systematic evidence that product quality has improved sufficiently in the years since.
The shelf-life problem is compounded by a labelling convention that favours manufacturers over consumers. When a product states a CFU count “at time of manufacture,” it is being technically accurate. When it states CFU “at time of expiry” or “guaranteed at expiry,” that is a meaningfully different and more honest claim. Many products do not specify which standard they are using. Even those that do guarantee counts at expiry depend on the consumer storing the product correctly, in a cool, dry place, away from heat and moisture. Supplements kept on a kitchen shelf in a warm home may see viability decay considerably faster than the stated shelf life assumes.
There is also a subtler point about what CFU actually measures. Colony-forming units count bacteria that are capable of forming colonies in laboratory culture conditions. Bacteria that are alive but in a stressed or dormant state, described technically as viable but non-culturable, may not register accurately in a standard CFU count. Research on synbiotic shelf life has demonstrated that the rate of loss in cultivability by CFU counts can be faster than the actual loss of membrane integrity, suggesting that CFU figures may underestimate the true number of living organisms while simultaneously overstating the number capable of activity in the gut. The label number, in short, is an approximation built on a measurement convention that has its own limitations.
None of this means that CFU is a meaningless metric. It is the best standardised measure currently available, and higher counts from verified, stable products remain preferable to lower ones. What it does mean is that a CFU number printed on packaging, without information about how that number was determined and what it represents at the point of consumption, tells you considerably less than it appears to.
The Regulation Gap Nobody Talks About
Human food supplements in the UK are regulated under the Food Supplements (England) Regulations 2003 and overseen by the Food Standards Agency. Veterinary medicines are regulated by the Veterinary Medicines Directorate. Pet supplements, however, occupy a different space. They are not classified as veterinary medicines unless they make specific disease claims. They are not subject to the same pre-market approval requirements. There is no mandatory independent verification of the contents before a product reaches the shelf.
The practical consequence is that manufacturers of dog gut supplements can list ingredients, claim CFU counts, and use bacterial names on their labels with a level of quality-control accountability that would not be accepted in the human pharmaceutical or veterinary medicine sectors. The Veterinary Medicines Directorate’s position is that products making therapeutic claims require authorisation, but the line between a health-supporting supplement and a therapeutic product is one that the industry has, historically, managed to its own advantage.
The evidence from product testing reflects this gap. Weese and Martin’s analysis found that 32% of tested veterinary probiotic products had misspelled bacterial names on their labels. Three products listed organisms that, to the researchers’ knowledge, did not exist.³ A more recent study examining probiotic product labelling in a retail pharmacy context documented non-existent bacterial names, missing CFU data, and absent strain declarations, noting these as consistent findings across a range of products.⁷ While that study was conducted in Ghana and its geographic scope should be noted, the pattern of labelling inaccuracy it describes is consistent with what has been found in North American veterinary product testing. Jan Suchodolski, one of the most cited researchers in canine gut health, has observed that most commercial product labels do not provide sufficient information about the probiotic strain and amount, and that many also state incorrect scientific names or incorrectly spelled bacterial names, indicating potential poor quality control.⁵
This is not an indictment of every product on the market. There are manufacturers who invest in third-party testing, who guarantee CFU counts at expiry rather than manufacture, and who use correctly identified, strain-designated organisms. But the regulatory environment does not require them to, which means a consumer reading a label has no way of distinguishing between a rigorously produced product and one that was assembled with considerably less care.
The ingredients list, in this context, is not just incomplete. It is operating without any mandatory verification that it is accurate.
What the Label Cannot Tell You About Your Dog’s Gut
Even a perfect label, one with correct strain designations, verified CFU counts guaranteed at expiry, and a fully accurate species list, would still be missing the most important variable: your dog.
The canine gut microbiome is not a fixed entity. It is a living ecosystem shaped continuously by diet, age, genetics, environment, stress, antibiotic history, and the complex metabolic interactions between microbial communities and their host.⁵ Research by Pilla and Suchodolski describes the gut microbiome as contributing to host metabolism, pathogen protection, and immune system education, and affecting, directly or indirectly, most physiological functions of the host. The same paper notes that while age, diet, and other environmental factors play a role in maintaining a healthy microbiome, the alterations they cause are generally smaller than the alterations found in diseased or dysbiotic animals.⁵
What this means practically is that two dogs eating the same supplement may have entirely different responses. A dog with a history of repeated antibiotic treatment has a microbiome that looks very different from one that has never been exposed to antibiotics. A dog eating a highly processed diet has a different fermentation profile from one fed a diet rich in diverse plant fibres. A senior dog’s gut community has shifted in composition from the same dog at two years old. Breed, it turns out, also matters: studies have shown breed-specific differences in the relative abundance of key bacterial phyla, including Fusobacteria.⁵
Probiotics introduced into this environment do not simply colonise and persist. Research indicates that most probiotic organisms are transient residents rather than permanent colonisers of the gut.⁵ They pass through the gastrointestinal tract and the metabolites they produce during that transit, including antimicrobial peptides, short-chain fatty acids, and immunomodulatory compounds, are thought to account for much of their effect. Whether those metabolites are beneficial depends on the overall microbial context they encounter. A probiotic strain that produces butyrate in a human clinical trial is producing it into a specific microbial environment, at a specific dose, under specific conditions. The translation to a different species, a different gut environment, and a different formulation is not automatic.
The label tells you what is in the product. It cannot tell you how that product will interact with the unique microbial ecology that your dog has been building across its lifetime. That ecology is the variable that matters most, and it is the one that no ingredients panel can account for.
This is the heart of what whole-dog gut thinking means. The gut is not a simple input-output system where adding beneficial organisms produces a predictable result. It is a complex, adaptive ecosystem with its own history and its own logic. Supporting it effectively requires thinking about the whole picture: the diet that feeds the microbial community, the diversity of inputs that sustain it, the formulation integrity that ensures active ingredients survive long enough to do anything, and the research base that tells us whether a particular strain, in a particular species, has actually been shown to matter.
What to Actually Look For on a Label
The limitations described above do not mean that gut supplements are without value. They mean that the ingredients list alone is an unreliable guide to value. Here is what a more informative assessment looks like.
Strain-level identification. A supplement that lists only genus and species is withholding the information you need to evaluate its evidence base. Look for products that provide a full strain designation, for example Lactobacillus acidophilus NCFM or Bacillus velezensis DSM 15544. That designation is what connects a product to published clinical research. Without it, any efficacy claims are unsupported.
Viability guarantee at expiry, not at manufacture. A CFU count that is not qualified is almost always measured at manufacture. Look for products that explicitly state viability is guaranteed at the point of expiry. This is a stronger commitment and requires more rigorous quality control and formulation stability.
Canine-specific research. Human probiotic research is not canine probiotic research. Look for products that reference clinical evidence in dogs, not just evidence from human trials or rodent models. The canine evidence base is smaller and harder to build, which is precisely why it matters whether a manufacturer has invested in it.
Formulation integrity. Live organisms need to survive the manufacturing process, storage, transit, and the journey through the stomach before they reach the gut. Encapsulation technology, protective coatings, and careful packaging design all affect whether what is on the label is still viable at the point of delivery. A product that has invested in formulation science will typically say so. One that has not will often not mention it.
Transparency about sourcing and testing. Third-party testing, certificate of analysis availability, and clearly stated quality-control standards are indicators that a manufacturer is confident in what their product actually contains. These are not legally required. Their presence is therefore a meaningful differentiator.
A broader formulation philosophy. A single probiotic strain added to an otherwise undistinguished formula is a different proposition from a product designed around a coherent understanding of how the canine gut works, including the prebiotic substrates that feed beneficial bacteria, the postbiotic metabolites that result, and the systemic effects that flow from a healthy gut environment. The ingredients list, read in isolation, cannot convey that philosophy. But looking at the full formulation, and the reasoning behind it, can.
The dog owner in the pet shop, comparing two labels, is doing something entirely reasonable. The problem is not with the instinct to read carefully. The problem is that the system of labelling and regulation does not require labels to carry the information that a careful reading would benefit from. Understanding that gap is the first step to moving beyond it.
Your dog’s gut is not a problem to be solved with a single ingredient. It is a complex, living system that rewards informed, consistent, whole-body support. The label is the beginning of that conversation. It is rarely the end of it.
References
- Suchodolski JS. Intestinal microbiota of dogs and cats: a bigger world than we thought. Vet Clin North Am Small Anim Pract. 2011;41(2):261-272. doi: 10.1016/j.cvsm.2010.12.006. PMID: 21486635.
- Schmitz S, Suchodolski JS. Understanding the canine intestinal microbiota and its modification by pro-, pre- and synbiotics – what is the evidence? Vet Med Sci. 2016;2(2):71-94. doi: 10.1002/vms3.17. PMID: 29067182. PMC: PMC5645859.
- Weese JS, Martin H. Assessment of commercial probiotic bacterial contents and label accuracy. Can Vet J. 2011;52(1):43-46. PMID: 21461205. PMC: PMC3003573.
- Swanson KS, Dowd SE, Suchodolski JS, Middelbos IS, Vester BM, Barry KA, Nelson KE, Torralba M, Henrissat B, Coutinho PM, Cann IK, White BA, Fahey GC Jr. Phylogenetic and gene-centric metagenomics of the canine intestinal microbiome reveals similarities with humans and mice. ISME J. 2011;5(4):639-649. doi: 10.1038/ismej.2010.162. PMC: PMC3105739.
- Pilla R, Suchodolski JS. The role of the canine gut microbiome and metabolome in health and gastrointestinal disease. Front Vet Sci. 2020;6:498. doi: 10.3389/fvets.2019.00498. PMID: 31993446. PMC: PMC6971114.
- Cornell University Riney Canine Health Center. The power of probiotics. Available at: https://www.vet.cornell.edu/departments-centers-and-institutes/riney-canine-health-center/canine-health-topics/power-probiotics. Accessed March 2026.
- Fredua-Agyeman M, Larbi EA. Inaccurate labelling practices in probiotic products: a regulatory shortfall in Accra, Ghana. PLoS One. 2025;20(5):e0322194. doi: 10.1371/journal.pone.0322194. PMID: 40435307. PMC: PMC12118974.
- Suchodolski JS. Probiotics, prebiotics, synbiotics, and intestinal health of dogs and cats. Today’s Veterinary Practice. 2022. Available at: https://todaysveterinarypractice.com.
Editorial Information
| Field | Detail |
|---|---|
| Published | [Date] |
| Last Updated | [Date] – see revision notes |
| Reviewed by | Glendon Lloyd Dip.Canine.Nutrition Dip.Dog.Nutrigenomics |
| Next Review | [Date + 12 months] |
| Author | Glendon Lloyd |
| Disclaimer | This article is for informational purposes only and does not constitute veterinary advice. Always consult a qualified veterinarian before making changes to your dog’s diet or supplement regimen. |
